wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26827437-4FE1F924-82C3-41FF-B091-50E59921C471
Q26827437-4FE1F924-82C3-41FF-B091-50E59921C471
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827437-4FE1F924-82C3-41FF-B091-50E59921C471
Vascular normalization and cancer immunotherapy
P2860
Q26827437-4FE1F924-82C3-41FF-B091-50E59921C471
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827437-4FE1F924-82C3-41FF-B091-50E59921C471
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0275b11937fe1dba0ae8341862df9b1f0582f6d7
P2860
Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206